Skip to main content
. 2001 Mar;85(3):259–264. doi: 10.1136/heart.85.3.259

Figure 3  .

Figure 3  

Major coronary events among the simvastatin treated patients in the Scandinavian simvastatin survival study (4S) according to LDL cholesterol concentrations achieved after one year of treatment. 4S supports the view that greater LDL reductions yield measurably improved clinical outcomes: 18.9% of patients with LDL cholesterol (LDL-C) concentrations between 3.3-6.9 mmol/l (127-266 mg/dl) had a major coronary event, compared with 11.0% of patients with LDL-C between 1.5-2.7 mmol/l (58-104 mg/dl). Reproduced from Pederson, Eur Heart J 1998;19(suppl M):M15-21, with permission of the publisher.